Stock listing
Arrowhead Pharmaceuticals, Inc.
Selected listing: ARWR · NASDAQ · USD · US
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Health Technology. Latest release Oct 7, 2026: Arrowhead Pharmaceuticals Granted Entry in the FDA STAR Pilot…
- Ticker
- NASDAQ:ARWR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.
Latest news from Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals Granted Entry in the FDA STAR Pilot Program for Plozasiran in Severe Hypertriglyceridemia
October 7, 2026
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
September 29, 2026
Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
September 15, 2026
Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences
September 3, 2026
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia
August 30, 2026
Events
Research Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. company profile
View the public company page for Arrowhead Pharmaceuticals, Inc. on 6ix.
Arrowhead Pharmaceuticals, Inc. news
Read company news and market updates connected to Arrowhead Pharmaceuticals, Inc..
Arrowhead Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Arrowhead Pharmaceuticals, Inc..
Alternate listings
HDP1:GETTEX
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
A2RR34:BMFBOVESPA
BR · BRL
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
A2AGYB:LSX
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
A2AGYB:LS
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
ARWR:BMV
MX · MXN
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
0HI3:LSE
GB · USD
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
ARWR:BOATS
US · USD
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
HDP1:TRADEGATE
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
HDP1:FWB
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
HDP1:SWB
DE · EUR
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
ARWR:BIVA
MX · MXN
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.
HDP1:BX
CH · CHF
Alternate listing for Arrowhead Pharmaceuticals, Inc.; the primary context on this page is ARWR:NASDAQ.